![]() |
Trials |
A Multicenter, Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations Who Have Progressed on Prior EGFR TKI TreatmentCancer type: Lung cancer Phase: II Principal Investigator: Fløtten Øystein Country: NO Keywords: Norway, Bergen Status: Completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01646125 |